Hepasil 140mg Tablet contains Silymarin 140mg, a standardized extract derived from the seeds of the milk thistle plant (Silybum marianum). It is primarily indicated for the management and supportive treatment of liver disorders, including hepatic inflammation, cirrhosis, and toxin-induced liver damage. Silymarin exhibits potent antioxidant properties by scavenging free radicals and enhancing cellular antioxidant defenses, thereby protecting hepatocytes from oxidative stress and promoting liver cell regeneration. Additionally, it stabilizes cell membranes, inhibits lipid peroxidation, and modulates inflammatory responses within hepatic tissue. Hepasil 140mg is commonly utilized as an adjunct therapy in cases of chronic hepatitis, alcoholic liver disease, and non-alcoholic fatty liver disease (NAFLD), contributing to improved liver function tests and symptomatic relief. The medication is generally well-tolerated, with a low incidence of adverse effects; however, patients should adhere to prescribed dosages and consult healthcare providers before use, especially if pregnant, lactating, or on concurrent medications. Hepasil 140mg Tablet is intended to support liver health and enhance the body’s natural detoxification processes, making it a valuable option in comprehensive hepatoprotective treatment regimens.